New vaccine shows promise for rare eye cancer

This early-stage trial tested a personalized vaccine made from a patient's own immune cells and tumor material for people with metastatic uveal melanoma, a rare eye cancer that has spread. The vaccine was added to standard treatments like immunotherapy or chemotherapy. The main goals were to check safety and tolerability, with 17 participants enrolled.